Abbreviations
UZL is one of the participating organisations on behalf of KUL. UZL is the largest Belgian University hospital and has a comprehensive multidisciplinary neuro-oncology team and works together with the Leuven Cancer Institute and Brain Tumor Focus Group and the Leuven Brain Institute.
What is KUL-UZL’s main role?
Running the retrospective clinical trial to feed data lake on GBM patients treated with immunotherapy approaches.
Running small scale proof-of-concept phase 0 clinical trial on anti-Gal1-si RNA formulations via transnasal delivery route in the context of DC-based vaccination strategy.
Which work packages is KUL-UZL involved in?
UZL contributes to work packages 2, 5, 7 and 8.
Who will represent KUL-UZL?
GLIOMATCH Partners
